3-Apr-2025 8:01 PM CST - Morningstar The Value of Moderna's mRNA Technology Is Obscured by Fears of a Hostile US Regulatory Environment Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due to uncertainties tied to an evolving virus and the changing competitive landscape for innovative vaccines.
3-Apr-2025 3:08 AM CST - The Motley Fool FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, last year, the company brought in $3.2 billion in revenue, compared to more than $19 billion at its peak in 2022 and a loss of $3.6 billion on a GAAP basis.
2-Apr-2025 7:08 AM CST - Benzinga 4MRNA : Moderna Options Trading: A Deep Dive into Market Sentiment Moderna had 40 mRNA development candidates in clinical development as of ... RSI indicators hint that the underlying stock may be approaching oversold. Next earnings are expected to be released in 29 days. 2 market experts have recently issued ratings ...
31-Mar-2025 9:29 PM CST - Investopedia Watch These Moderna Price Levels as Stock Sinks to 5-Year Low Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and Drug Administration's top vaccine official has resigned. Watch these key price levels on the weekly chart.
31-Mar-2025 4:16 PM CST - Seeking Alpha FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.
31-Mar-2025 12:58 PM CST - Yahoo Finance Why Moderna Stock Is Plummeting Today Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The steep decline comes as the S&P 500 and Nasdaq Composite lost 0.4% and 1.1%, respectively. The vaccine maker's shares tumbled following the resignation of a key U.
31-Mar-2025 10:52 AM CST - Investopedia Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter Marks, announced his resignation.Marks, who helped oversee the development of COVID-19 vaccines,
3-Apr-2025 8:01 PM CST - Morningstar The Value of Moderna's mRNA Technology Is Obscured by Fears of a Hostile US Regulatory Environment Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due to uncertainties tied to an evolving virus and the changing competitive landscape for innovative vaccines.
3-Apr-2025 3:08 AM CST - The Motley Fool FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, last year, the company brought in $3.2 billion in revenue, compared to more than $19 billion at its peak in 2022 and a loss of $3.6 billion on a GAAP basis.
2-Apr-2025 7:08 AM CST - Benzinga 4MRNA : Moderna Options Trading: A Deep Dive into Market Sentiment Moderna had 40 mRNA development candidates in clinical development as of ... RSI indicators hint that the underlying stock may be approaching oversold. Next earnings are expected to be released in 29 days. 2 market experts have recently issued ratings ...
31-Mar-2025 9:29 PM CST - Investopedia Watch These Moderna Price Levels as Stock Sinks to 5-Year Low Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and Drug Administration's top vaccine official has resigned. Watch these key price levels on the weekly chart.
31-Mar-2025 4:16 PM CST - Seeking Alpha FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.
31-Mar-2025 12:58 PM CST - Yahoo Finance Why Moderna Stock Is Plummeting Today Shares of Moderna (NASDAQ: MRNA) are falling on Monday. The steep decline comes as the S&P 500 and Nasdaq Composite lost 0.4% and 1.1%, respectively. The vaccine maker's shares tumbled following the resignation of a key U.
31-Mar-2025 10:52 AM CST - Investopedia Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' Key Takeaways Moderna and other vaccine stocks fell Monday after the Food and Drug Administration's vaccine chief, Peter Marks, announced his resignation.Marks, who helped oversee the development of COVID-19 vaccines,
